Evaluating the Feasibility of a Piezoelectric Smart Sensor as an Aid to Help Clinicians Screen for the Development of Pneumonia in an At-risk Population

ConditionsStroke End Stage Renal Failure on Dialysis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age21+

SponsorNational University Hospital, Singapore

About this trial

This proposed research aims to evaluate the feasibility of the piezoelectric sensor as an aid to help clinicians screen for the development of pneumonia in an at-risk population.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 21 years and above

Acute stroke patients (i.e. MRI or CT brain findings consistent with diagnosis) or ESRF patients on HD who are mentally competent and cognitively fit to provide consent.

Disqualifiers

Individuals who are unable to give informed consent

Individuals with active dermatological conditions

Trial design

Design model

Single group

Treatments tested in this trial

Piezoelectric sensor
Device
The piezoelectric sensor will be applied to the posterior chest wall of all recruited subjects once daily at one time point (excluding weekends, public holidays and discharge day) up to 2 weeks whilst he/she is warded, until pneumonia or fluid overload is detected and confirmed by CXR or the subject is discharged, whichever is earlier.

Treatment groups

50 Participants

are divided into 1 treatment group

Group A: Piezoelectric sensorExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Detection of pneumonia

The piezoelectric sensor detects abnormal chest sounds that is suggestive of pneumonia or fluid overload and is confirmed by CXR.

Time frame

3 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National University Hospital, Singapore

Lead sponsor

National University of Singapore

Collaborator

Source ClinicalTrials.gov

Apply now